Bailey Jeffrey Allen
SEC CIK 1500210 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Dir | 22.8K | — | $38.4K | 4 | 2024-11-08 | 2025-11-21 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-24 | 2025-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Dir | F - Tax | $15.68 | -2,716 | 22.8K | -11% | -$42.6K | |
| D | 2024-11-25 | 2024-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Dir | A - Grant | $0.00 | +12.1K | 25.5K | +91% | $0 |
| D | 2024-11-12 | 2024-11-08 | AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Dir | M - OptEx | — | +17.9K | 17.9K | New | — |
| D | 2024-11-12 | 2024-11-11 | AUPH | Aurinia Pharmaceuticals Inc. | Bailey Jeffrey Allen | Dir | S - Sale+OE | $8.43 | -4,557 | 13.4K | -25% | -$38.4K |
Purchase Sale Sale after option exercise All abbreviations